Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.
2.

Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.

Vlachou S, Paterson NE, Guery S, Kaupmann K, Froestl W, Banerjee D, Finn MG, Markou A.

Eur J Pharmacol. 2011 Mar 25;655(1-3):52-8. doi: 10.1016/j.ejphar.2011.01.009. Epub 2011 Jan 22.

3.

Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats.

Vlachou S, Guery S, Froestl W, Banerjee D, Benedict J, Finn MG, Markou A.

Psychopharmacology (Berl). 2011 May;215(1):117-28. doi: 10.1007/s00213-010-2119-x. Epub 2010 Dec 22.

4.

Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists.

Leslie CP, Bentley J, Biagetti M, Contini S, Di Fabio R, Donati D, Genski T, Guery S, Mazzali A, Merlo G, Pizzi DA, Sacco F, Seri C, Tessari M, Zonzini L, Caberlotto L.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6103-7. doi: 10.1016/j.bmcl.2010.08.041. Epub 2010 Aug 12.

PMID:
20813523
5.

Discovery process and characterization of novel carbohydrazide derivatives as potent and selective GHSR1a antagonists.

Sabbatini FM, Di Fabio R, Corsi M, Cavanni P, Bromidge SM, St-Denis Y, D'Adamo L, Contini S, Rinaldi M, Guery S, Savoia C, Mundi C, Perini B, Carpenter AJ, Dal Forno G, Faggioni F, Tessari M, Pavone F, Di Francesco C, Buson A, Mattioli M, Perdona' E, Melotto S.

ChemMedChem. 2010 Sep 3;5(9):1450-5. doi: 10.1002/cmdc.201000185. No abstract available.

PMID:
20593439
6.

Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats.

Maccioni P, Carai MA, Kaupmann K, Guery S, Froestl W, Leite-Morris KA, Gessa GL, Colombo G.

Alcohol Clin Exp Res. 2009 Oct;33(10):1749-56. doi: 10.1111/j.1530-0277.2009.01012.x. Epub 2009 Jul 1.

PMID:
19572981
7.

Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.

Letard S, Yang Y, Hanssens K, Palmérini F, Leventhal PS, Guéry S, Moussy A, Kinet JP, Hermine O, Dubreuil P.

Mol Cancer Res. 2008 Jul;6(7):1137-45. doi: 10.1158/1541-7786.MCR-08-0067.

8.

Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A.

J Pharmacol Exp Ther. 2008 Jul;326(1):306-14. doi: 10.1124/jpet.108.139204. Epub 2008 Apr 29.

9.

Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors.

Guery S, Floersheim P, Kaupmann K, Froestl W.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6206-11. Epub 2007 Sep 8.

10.

A convenient 3-step synthesis of 3-acetamido-6-arylpyridazines directed to novel Y5 receptor antagonist.

Guéry S, Rival Y, Wermuth CG, Renard P, Boutin JA.

Chem Pharm Bull (Tokyo). 2002 May;50(5):636-9.

Supplemental Content

Support Center